Oleic Acid

Oleic Acid

SCHEMBL5176449

CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.OCC(O)CO

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.77
▸ PPARD Q03181 5/20 0.77
▸ PPARA Q07869 5/20 0.77
▸ F7 P08709 5/20 0.77
▸ F3 P13726 5/20 0.77
▸ TERT O14746 3/20 0.77
▸ PTPN1 P18031 3/20 0.77
▸ HSD17B10 Q99714 3/20 0.77
▸ FABP4 P15090 3/20 0.77
▸ TOP1 P11387 3/20 0.77
▸ MAPT P10636 2/20 0.77
▸ BLM P54132 2/20 0.77
▸ LMNA P02545 2/20 0.77
▸ ALOX15 P16050 2/20 0.77
▸ DUSP3 P51452 2/20 0.77
▸ CYP19A1 P11511 2/20 0.77
▸ PTGS1 P23219 2/20 0.77
▸ NR4A2 P43354 2/20 0.77
▸ SIRT6 Q8N6T7 2/20 0.77
▸ PTPN7 P35236 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL10798920 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Glycerin SCHEMBL10796527 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL6574521 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL6002519 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL8848511 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL25405469 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL2457378 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL15049128 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL7931966 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL11276244 1.00 PPARG (0.77) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0903399-B1 Lubricant compositions containing thiophosphoric and dithiophosphoric acid esters CIBA SC HOLDING AG (CH) 2007-02-14 — — EP disclosed
EP-1054052-B1 Stabilized hydrotreated and hydrodewaxed lubricant compositions CIBA SC HOLDING AG (CH) 2006-06-28 — — EP disclosed
EP-1476137-A1 COMPOSITION COMPRISING LOW WATER SOLUBLE COMPOUNDS WITHIN POROUS CARRIERS PHARES PHARMACEUTICAL RESEARCH N.V. (AN) 2004-11-17 — — EP disclosed
US-20040019074-A1 Pharmaceutical compositions for sparingly soluble therapeutic agents CIBA-GEIGY CORPORATION 2004-01-29 — — US disclosed
US-20040018992-A1 Pharmaceutical compositions for sparingly soluble therapeutic agents CIBA-GEIGY CORPORATION 2004-01-29 — — US disclosed
WO-2003063835-A1 COMPOSITION COMPRISING LOW WATER SOLUBLE COMPOUNDS WITHIN POROUS CARRIERS PHARES PHARMACEUTICAL RESEARCH N.V. (NL) 2003-08-07 — — WO disclosed
US-6531429-B2 Lubricant compositions comprising thiophosphoric acid esters and dithiophosphoric acid esters CIBA SPECIALTY CHEMICALS CORPORATION 2003-03-11 — — US disclosed
US-20020099067-A1 Pharmaceutical compositions for sparingly soluble therapeutic agents POSANSKI ULRICH (DE) 2002-07-25 — — US disclosed
US-6410490-B1 OIL ADDITIVE MIXTURE CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-25 — — US disclosed
US-20020016266-A1 Lubricant compositions comprising thiophosphoric acid esters and dithiophosphoric acid esters FLETSCHINGER MICHAEL (DE) 2002-02-07 — — US disclosed
EP-1092429-A1 Pharmaceutical preparations for drugs of low solubility Novartis AG (CH) 2001-04-18 — — EP disclosed
EP-1054052-A2 Stabilized hydrotreated and hydrodewaxed lubricant compositions Ciba SC Holding AG (CH) 2000-11-22 — — EP disclosed
EP-0903399-A1 Lubricant compositions containing thiophosphoric and dithiophosphoric acid esters Ciba SC Holding AG (CH) 1999-03-24 — — EP disclosed
EP-0710104-A1 PHARMACEUTICAL COMPOSITIONS FOR HARDLY SOLUBLE ACTIVE SUBSTANCES Novartis AG (CH) 1996-05-08 — — EP disclosed
EP-0710103-A1 PHARMACEUTICAL COMPOSITIONS FOR HARDLY SOLUBLE ACTIVE SUBSTANCES Novartis AG (CH) 1996-05-08 — — EP disclosed
WO-1995001786-A1 PHARMACEUTICAL COMPOSITIONS FOR HARDLY SOLUBLE ACTIVE SUBSTANCES CIBA-GEIGY AG (CH) 1995-01-19 — — WO disclosed
WO-1995001785-A1 PHARMACEUTICAL COMPOSITIONS FOR HARDLY SOLUBLE ACTIVE SUBSTANCES SANDOZ LTD. (CH) 1995-01-19 — — WO disclosed
Send feedback